T1	Procedure 11 42	left atrial appendage occlusion
T2	Qualifier 0 10	successful
R1	Has_qualifier Arg1:T1 Arg2:T2	
T3	Device 48 61	Amulet device
T4	Temporal 62 99	within 37 days prior to randomization
R2	AND Arg1:T1 Arg2:T3	
R3	Has_temporal Arg1:T1 Arg2:T4	
T5	Procedure 117 142	dual antiplatelet therapy
T6	Drug 144 155	clopidogrel
T7	Drug 160 180	acetylsalicylic acid
T8	Scope 144 180	clopidogrel and acetylsalicylic acid
R4	Has_scope Arg1:T5 Arg2:T8	
T9	Procedure 190 219	left atrial appendage closure
T10	Temporal 182 237	between left atrial appendage closure and randomization
T11	Reference_point 224 237	randomization
T12	Reference_point 190 219	left atrial appendage closure
R5	multi Arg1:T12 Arg2:T9	
T13	Scope 190 237	left atrial appendage closure and randomization
R6	Has_scope Arg1:T10 Arg2:T13	
T14	Person 253 256	age
T15	Value 257 274	18 years or older
T16	Temporal 275 323	at the time of signing the informed consent form
T17	Reference_point 290 323	signing the informed consent form
R7	Has_index Arg1:T16 Arg2:T17	
R8	Has_value Arg1:T14 Arg2:T15	
R9	Has_temporal Arg1:T14 Arg2:T16	
T18	Post-eligibility 325 507	participant is willing to follow all study procedures; especially randomized antiplatelet treatment regimen and follow-up visits with transesophageal echocardiography when applicable
T19	Informed_consent 509 571	participant is willing to sign the study informed consent form
